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Résumé en
anglais
Red wine polyphenolic compounds (RWPC) are reported to exert vasculoprotective
properties on endothelial cells, involving nitric oxide (NO) release via a redox-sensitive
pathway. This NO release involves the activation of the estrogen receptor-alpha (ERα).
Paradoxical effects of a RWPC treatment occur in a rat model of post-ischemic
neovascularization, where a low-dose is pro-angiogenic while a higher dose is anti-
angiogenic. NO and ERα are key regulators of mitochondrial capacity, and
angiogenesis is a highly energetic process associated with mitochondrial biogenesis.
However, whether RWPC induces changes in mitochondrial capacity has never been
addressed. We investigated the effects of RWPC at low (10(-4)g/l, LCP) and high
concentration (10(-2)g/l, HCP) in human endothelial cells. Mitochondrial respiration,
expression of mitochondrial biogenesis factors and mitochondrial DNA content were
assessed using oxygraphy and quantitative PCR respectively. In vitro capillary
formation using ECM gel(®) was also performed. Treatment with LCP increased
mitochondrial respiration, with a maximal effect achieved at 48h. LCP also increased
expression of several mitochondrial biogenesis factors and mitochondrial DNA
content. In contrast, HCP did not affect these parameters. Furthermore, LCP
modulated both mitochondrial capacity and angiogenesis through mechanisms
sensitive to ER, NADPH oxidase and NO-synthase inhibitors. Finally, the inhibition of
mitochondrial protein synthesis abolished the pro-angiogenic capacity of LCP. These
results suggest a possible association between the modulation of mitochondrial
capacity by LCP and its pro-angiogenic activity. These data provide evidence for a role
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